Prediction of adverse pregnancy outcome by the presence of lupus anticoagulant, but not anticardiolipin antibody, in patients with antiphospholipid antibodies. - Wikidata - awgldk - TriplyDB

Prediction of adverse pregnancy outcome by the presence of lupus anticoagulant, but not anticardiolipin antibody, in patients with antiphospholipid antibodies.

Prediction of adverse pregnancy outcome by the presence of lupus anticoagulant, but not anticardiolipin antibody, in patients with antiphospholipid antibodies.

http://www.wikidata.org/entity/Q35977256

about

Antiphospholipid Antibodies and Antiphospholipid Syndrome during Pregnancy: Diagnostic Concepts Managing lupus patients during pregnancy The clinical significance of antiphospholipid antibodies in systemic lupus erythematosus Related factors of fetal loss in Chinese women with systemic lupus erythematosus: data from Chinese SLE Treatment and Research Group registry IV.Risk factors of systemic lupus erythematosus flares during pregnancy.Current treatment of antiphospholipid syndrome: lights and shadows.Lupus anticoagulant, disease activity and low complement in the first trimester are predictive of pregnancy loss Pregnancy Outcomes in Chinese Patients with Systemic Lupus Erythematosus (SLE): A Retrospective Study of 109 Pregnancies Fertility and pregnancy in rheumatoid arthritis and systemic lupus erythematosus.EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome Pregnancy outcomes among African-American patients with systemic lupus erythematosus compared with controls Increased usage of special educational services by children born to mothers with systemic lupus erythematosus and antiphospholipid antibodies Treatment of refractory obstetric antiphospholipid syndrome: the state of the art and new trends in the therapeutic management.A role for uric acid and the Nalp3 inflammasome in antiphospholipid antibody-induced IL-1β production by human first trimester trophoblast.Interferon-α and angiogenic dysregulation in pregnant lupus patients who develop preeclampsia.Systemic lupus erythematosus and thrombosis.Changes in Circulating ProAMH and Total AMH during Healthy Pregnancy and Post-Partum: A Longitudinal Study.Reactivity to the p305 Epitope of the α1G T-Type Calcium Channel and Autoimmune-Associated Congenital Heart Block Angiogenic factor imbalance early in pregnancy predicts adverse outcomes in patients with lupus and antiphospholipid antibodies: results of the PROMISSE study.Lupus anticoagulant is the main predictor of adverse pregnancy outcomes in aPL-positive patients: validation of PROMISSE study results.Sex ratios among children of lupus pregnancies.Anticoagulation in management of antiphospholipid antibody syndrome in pregnancy.The antiphospholipid syndrome: still an enigma Latest advances in connective tissue disorders.Assessment of the independent associations of IgG, IgM and IgA isotypes of anticardiolipin with thrombosis in SLE.Antiphospholipid antibody-induced miR-146a-3p drives trophoblast interleukin-8 secretion through activation of Toll-like receptor 8.Persistent antiphospholipid antibodies do not contribute to adverse pregnancy outcomes.Pregnancy and autoimmune connective tissue diseases 2013 update: Hopkins lupus cohort.Predictors of Pregnancy Outcomes in Patients With Lupus: A Cohort Study.Management of pregnancy in systemic lupus erythematosus.Pregnancy and antiphospholipid syndrome.Regulatory T cells in systemic lupus erythematosus and pregnancy.Management of women with recurrent pregnancy losses and antiphospholipid antibody syndrome.Top 10 clinical research developments in antiphospholipid syndrome.Update on the current recommendations and outcomes in pregnant women with antiphospholipid syndrome.High-risk pregnancy and the rheumatologist.Laboratory evaluation of anti-phospholipid syndrome: a preliminary prospective study of phosphatidylserine/prothrombin antibodies in an at-risk patient cohort.The Role of Anticoagulants in the Prevention of Pregnancy Complications.Socioeconomic Status Contributes to Racial/Ethnic Disparities in Adverse Pregnancy Outcomes among Women with Systemic Lupus Erythematosus.

P2860

Q26852537-16A8B634-CDC4-409F-B060-4B18145D1094 Q27002228-FE96DB37-5D57-4C99-BDA8-52E3E7D173C0 Q28072610-40A43C10-9036-4440-85B4-230FBC02FA27 Q30882151-2551E8AC-7D04-4B07-A347-66BA44315311 Q33418676-00B78972-B16A-4D87-A4E3-3B463CFDF48E Q33423959-300AA6DF-9016-4E3E-94C7-6DB2586429EA Q33428578-80C980AB-77B1-4F4F-AF1E-A64D07E28A3A Q33434059-6D09AF92-8B5C-4C8C-8C21-F67D5C7DEF13 Q33654712-CD9952DF-975B-423C-98B2-8218319B7AF2 Q33731711-FD983392-1090-403B-8425-FB39ED834A34 Q34414346-BE62C833-44CA-432A-AE23-FE4BAF2E1EE6 Q34424615-2FCA19D0-29C8-4433-A49C-0B08E9267E54 Q34476952-41A5D3FB-EBB0-4ABB-8BCC-B1B27BF41701 Q34769721-B3E1488A-F2A8-4C1B-977F-A0A1A06172CE Q35236547-2714DF75-9BD4-4D48-BA1C-52D694645E7B Q35530248-74A1AAAA-8A1A-4A76-B9AB-754CE36FA7B6 Q36128530-FA4A75A9-4435-470F-B6C9-0E3BAE8D5BD5 Q36141367-540EB9A1-3B34-4D63-971A-0B628C60292E Q36421501-C85F9034-F56B-4EDA-A2FB-BDFD0C310F32 Q36472645-32F0C57E-80E1-49EE-B6EF-C050922D0F7C Q36504122-893164C8-124B-4C6F-B102-83F24469E046 Q36879113-D9179FE2-364F-47CC-BA78-0CD9A2D82F52 Q36928593-219F2B30-D1B1-4F9F-A5CF-F8A5B0174FB7 Q37058776-F90AEF14-C71A-4AF1-9C95-09ABFA6EAA70 Q37063656-39D60032-9855-475F-B98D-B5B25AB16B73 Q37087437-7B4ED02A-4F8E-411D-B527-D89BAD9E0137 Q37090069-D9C3F985-A732-4A4E-ABFF-30AEE7B336B4 Q37100267-6DE474DC-8078-474A-8353-58E24511346A Q37131283-D6631262-D1EE-4443-9814-C2AFE5EE6B0E Q37420173-CDAE4F46-DEE4-42C7-B187-03F1224A57C7 Q38036105-034E7128-7F69-4BFB-90CA-EE8B931352C2 Q38070831-54617A65-9CD0-45D1-93ED-943C7D8C1014 Q38080562-49506976-3481-4A6D-93CF-7A7A4CB2A3FF Q38092150-1A1E0107-91E2-4D4E-8C36-F752241EEC2D Q38135335-9EC14EF4-9EE9-4958-AD33-63CFD93A427A Q38258585-C0A2B7A2-3E44-4D0B-B136-4C10F38CB208 Q38283472-A0B774AB-2255-4804-A46E-61841BF1B9F9 Q38293418-B79E9F34-55C8-4B8E-AC7A-04FE5484AD51 Q38632931-B2367BCF-C3B9-4FC2-8AA5-88B094EE6C47 Q38798999-D634985B-691E-474B-ABDF-C252120F0456

P2860

Prediction of adverse pregnancy outcome by the presence of lupus anticoagulant, but not anticardiolipin antibody, in patients with antiphospholipid antibodies.

http://www.wikidata.org/entity/Q35977256

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Prediction of adverse pregnanc ...... h antiphospholipid antibodies.

@ast

Prediction of adverse pregnanc ...... h antiphospholipid antibodies.

@en

type

label

Prediction of adverse pregnanc ...... h antiphospholipid antibodies.

@ast

Prediction of adverse pregnanc ...... h antiphospholipid antibodies.

@en

prefLabel

Prediction of adverse pregnanc ...... h antiphospholipid antibodies.

@ast

Prediction of adverse pregnanc ...... h antiphospholipid antibodies.

@en

P1433

Q35977256-A14312AC-B9B1-4E8B-82A7-BD4FDD89E73D

P1476

Q35977256-FD39D794-8BBA-4A46-8E6A-826847336E5C

P2093

Q35977256-120BB940-8EEC-4533-AA3D-15F95513F2F4

Q35977256-1DBEFE56-9831-464F-8EF8-643E5129FCA7

Q35977256-224E0891-B840-4899-9F77-FA01E33AEB7C

Q35977256-4FB92676-3397-4BA9-9E0C-7F3E91AA54C4

Q35977256-5D24071F-4406-443F-9157-7A540A0A2161

Q35977256-70A00EBF-0FC8-41A6-8B6F-735C5A3508FE

Q35977256-8A2FE28C-3395-4242-BF9F-3DBD9986A131

Q35977256-9309FE9E-EDCD-40F0-A828-C34E1E1B5667

Q35977256-BD9AAA96-416B-4094-81A0-8244DBC25459

Q35977256-F8DD7CC8-1BDF-451E-A83A-2448335E3297

P2860

Q35977256-06A51511-40CF-4B06-A06C-42364B486AC4

Q35977256-1FBC390A-179D-4A11-9069-753F9D00CC16

Q35977256-285F8363-0A0D-4D9E-85EA-FC47EAD5A4CC

Q35977256-29FA88FE-AD60-410A-8192-4E5D9D1A1893

Q35977256-527023F1-CEAA-44DF-8225-A94A97C83908

Q35977256-561ACD9F-A1A8-4E7D-93F3-CC3771FE0316

Q35977256-5839183A-24AC-43EB-8D96-FBF0ECCD2EBC

Q35977256-5ABB640F-7ACA-4DC0-9B52-4562BBA38DD9

Q35977256-5F142173-7A14-4341-B69A-1E188903FE91

Q35977256-97E989B0-D0C3-4C02-A293-F333B3D89559

P304

Q35977256-79A510AA-E7AF-482F-A0E2-84E5E4A04EF3

P31

Q35977256-ACF5523B-73CA-4A6E-9A83-8448A43E91DF

P356

Q35977256-760FDE40-8EEB-4535-8344-D73AA5955D94

P433

Q35977256-64958A9B-AB48-4090-9112-470D2842F29E

P478

Q35977256-66458092-8DBE-4516-ACF6-8F92BEAE7BAE

P50

Q35977256-0709A8FB-5187-4979-83DD-DE95F661D102

Q35977256-E5789E02-8505-4AE4-96F8-123C15EA67B4

P577

Q35977256-5DAAA5F3-04E7-45B7-BA8E-6534378406AF

P5875

Q35977256-74880A59-3D81-4AD4-A89F-595F8EF0E2DF

P698

Q35977256-8C47E7B2-7A8F-4346-9494-4CAF0719FFA6

P921

Q35977256-A7F72D4B-099E-472E-AAB1-E1EAD66C4A7E

Q35977256-E8F56CB3-67DC-493F-BCEA-4E5FA5686358

Q35977256-FC868A12-1F23-4E69-8C53-7F767E385856

P932

Q35977256-55264844-A088-4FA0-8557-C6FDD638437B

P356

P1433

Arthritis & Rheumatology

P1476

Prediction of adverse pregnanc ...... h antiphospholipid antibodies.

@en

P2093

Carl A Laskin

http://www.w3.org/2001/XMLSchema#string

D Ware Branch

http://www.w3.org/2001/XMLSchema#string

Jane E Salmon

http://www.w3.org/2001/XMLSchema#string

Jill Buyon

http://www.w3.org/2001/XMLSchema#string

Joan Merrill

http://www.w3.org/2001/XMLSchema#string

Lisa Sammaritano

http://www.w3.org/2001/XMLSchema#string

Marta Guerra

http://www.w3.org/2001/XMLSchema#string

Mary D Stephenson

http://www.w3.org/2001/XMLSchema#string

Mimi Kim

http://www.w3.org/2001/XMLSchema#string

T Flint Porter

http://www.w3.org/2001/XMLSchema#string

P2860

Use of the dilute Russell viper venom time (dRVVT): its importance and pitfalls

Treatment of antiphospholipid syndrome in pregnancy--a systematic review of randomized therapeutic trials

The obstetric antiphospholipid syndrome

Real world experience with antiphospholipid antibody tests: how stable are results over time?

International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)

Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus

A modified poisson regression approach to prospective studies with binary data

International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop.

ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002.

Antiphospholipid antibodies as cause of pregnancy loss.

P304

2311-2318

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ART.34402

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

64

http://www.w3.org/2001/XMLSchema#string

P50

Michael D. Lockshin

Michelle A. Petri

P577

2012-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221775528

http://www.w3.org/2001/XMLSchema#string

P698

22275304

http://www.w3.org/2001/XMLSchema#string

P921

anticoagulation

P932

3357451

http://www.w3.org/2001/XMLSchema#string